23 May 2012
Candidate to Market was a one-day course held on 16 May 2012, which explained the fate of a chemist's compound once it leaves his or her hands and goes on the journey through to clinical development. The meeting was aimed at scientists in the industrial and academic fields.
Available Conference Papers:
- Programme/Flyer
-
How to make the best use out of Process R&D
David Lathbury, AMRI Global -
Delivering the best formulation to the right patients
George Kirk, AstraZeneca R&D Alderley Park -
Toxicology and safety pharmacology and metabolic studies (in vitro and in vivo)
Steve Horner, AstraZeneca R&D Alderley Park -
Drug interactions, from bench to bedside
Michael Griffin, Cyprotex Discovery Ltd -
Clinical trials: why, how and when,
Kirsty Kwiatkowski, Vernalis (R&D) Ltd
Visit Blog